Mårten Fernö
201 – 210 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1996
-
Mark
Uterus and endometrium: Flow cytometric DNA analysis in endometriotic tissue compared to normal uterine endometrium
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
(
- Contribution to journal › Article
-
Mark
Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis
(
- Contribution to journal › Article
-
Mark
Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas
(
- Contribution to journal › Article
- 1995
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
(
- Contribution to journal › Article
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
(
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
(
- Contribution to journal › Article